InvestorsHub Logo
Followers 32
Posts 794
Boards Moderated 0
Alias Born 03/02/2020

Re: None

Tuesday, 06/23/2020 4:49:16 PM

Tuesday, June 23, 2020 4:49:16 PM

Post# of 233144
AZN Looks like a perfect suitor for Cytodyn. They were just in the news looking to merge with Gilead. Gilead wasn't interested. Cydy With Covid-19 approval could spark AZN interest. With a 1 for 1 stock trade. Cydy would get $53/share or $35 billion for the company. AZN gets Leronlimab. AZN dividend is currently $1.40 /Share with issuance of 700 million more shares they would only need $1 billion to keep the same pay-out. They should be able to do that with hands tied behind their backs. Everyone wins. Cytodyn shareholders still get to keep Leronlimab and any potential increases in revenue. Or they can sell and get $53/ share. AZN gets a drug with potential out the wazo. dividend payout stays the same or they use the potential cash from Leronlimab to increase dividends. This is something that could be sold to all shareholders. What do you think. Cytodyn.

This is a quote from Cytodyn's Facebook page. Interesting.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News